Published in Endocr Pract on July 27, 2009
Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril (2010) 0.92
Psychological investigation in patients with polycystic ovary syndrome. Health Qual Life Outcomes (2013) 0.86
Self-immolation and its adverse life-events risk factors: results from an Iranian population. J Inj Violence Res (2014) 0.78
Mindfulness-based stress reduction for overweight/obese women with and without polycystic ovary syndrome: design and methods of a pilot randomized controlled trial. Contemp Clin Trials (2015) 0.77
Views of women with polycystic ovary syndrome: a qualitative study in an ethnically diverse sample. Endocr Connect (2017) 0.76
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril (2008) 5.31
Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab (2006) 4.56
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab (2010) 2.48
Premicroalbuminuria in women with polycystic ovary syndrome: a metabolic risk marker. Endocr Pract (2008) 1.51
Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet Gynecol (2011) 1.43
St John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist. Psychosomatics (2003) 1.10
Pre-analytical errors: everything that happens to the specimen up to the point of testing. Fertil Steril (2002) 1.07
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause. Endocr Pract (2006) 1.07
Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol (2007) 1.03
A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome. Fertil Steril (2002) 0.96
Obesity and the polycystic ovary syndrome. Med Clin North Am (2007) 0.89
Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril (2011) 0.88
Kava monograph: a clinical decision support tool. J Herb Pharmacother (2002) 0.87
Risk of cardiovascular events in mothers of women with polycystic ovary syndrome. Endocr Pract (2008) 0.84
An evidence-based systematic review of Aloe vera by the natural standard research collaboration. J Herb Pharmacother (2007) 0.84
Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome. Endocrine (2012) 0.82
An evidence-based systematic review of bilberry (Vaccinium myrtillus) by the Natural Standard Research Collaboration. J Diet Suppl (2009) 0.81
FEM1A is a candidate gene for polycystic ovary syndrome. Gynecol Endocrinol (2005) 0.80
Pancreatic β-cell dysfunction in polycystic ovary syndrome: the role of metformin. Endocr Pract (2012) 0.79
Chaparral monograph:a clinical decision support tool. J Herb Pharmacother (2003) 0.78
Red clover (Trifolium pratense) monograph: a clinical decision support tool. J Herb Pharmacother (2002) 0.77
An evidence-based systemic review Echinacea E. angustifolia DC, E. pallida, E. purpurea by the Natural Standard Research Collaboration. J Herb Pharmacother (2005) 0.77
Psychoanalytic reflections through the prism of September 11, 2001. Psychoanal Study Child (2011) 0.75
A psychodynamic understanding of conversion nonepileptic seizures in a young woman with acquired blindness. CNS Spectr (2008) 0.75